GH Research (GHRS) Operating Leases (2023 - 2026)
GH Research (GHRS) posted quarterly Operating Leases of $365000.0 for Q4 2025, down 1.08% year-over-year from $369000.0 in Q4 2024, and little changed quarter-over-quarter from $365000.0 in Q3 2025.
GH Research (GHRS) Operating Leases (2023 - 2026) Analysis & Trends
GH Research's Operating Leases history runs 3 years deep, the most recent figure standing at $365000.0 for Q4 2025.
- In Q4 2025, Operating Leases fell 1.08% year-over-year to $365000.0; the TTM figure through Dec 2025 stood at $365000.0 (down 1.08% YoY), while the FY2025 annual figure was $365000.0, down 1.08% from the prior year.
- Operating Leases for Q4 2025 stood at $365000.0, roughly flat from $365000.0 in the prior quarter.
- The five-year high for Operating Leases was $1.0 million in Q4 2023, with the low at $336000.0 in Q1 2025.
- The 3-year median for Operating Leases is $477500.0 (2024), against an average of $541583.3.
- The sharpest annual moves came in 2024 and 2025: Operating Leases sank 63.1% in 2024, then decreased 1.08% in 2025.
- GH Research's Operating Leases stood at $1.0 million in 2023, then tumbled by 63.1% to $369000.0 in 2024, then slipped by 1.08% to $365000.0 in 2025.
- Business Quant data shows GHRS's Operating Leases at $365000.0 in Q4 2025, $365000.0 in Q3 2025, and $364000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | GH Research | 2.02 Bn | 1.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Dec 31, 2025 | 365,000.00 |
| Sep 30, 2025 | 365,000.00 |
| Jun 30, 2025 | 364,000.00 |
| Mar 31, 2025 | 336,000.00 |
| Dec 31, 2024 | 369,000.00 |
| Sep 30, 2024 | 458,000.00 |
| Jun 30, 2024 | 497,000.00 |
| Mar 31, 2024 | 561,000.00 |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 661,000.00 |
| Jun 30, 2023 | 732,000.00 |
| Mar 31, 2023 | 791,000.00 |